370 related articles for article (PubMed ID: 26330562)
21. Accuracy, Reproducibility and User Experience With Standardized Instructions for Measurement of Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease.
Bevilacqua M; Hague CJ; Romann A; Levin A
Can Assoc Radiol J; 2023 May; 74(2):343-350. PubMed ID: 36063401
[TBL] [Abstract][Full Text] [Related]
22. Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function.
Boertien WE; Meijer E; de Jong PE; ter Horst GJ; Renken RJ; van der Jagt EJ; Kappert P; Ouyang J; Engels GE; van Oeveren W; Struck J; Czerwiec FS; Oberdhan D; Krasa HB; Gansevoort RT
Am J Kidney Dis; 2015 Jun; 65(6):833-41. PubMed ID: 25600953
[TBL] [Abstract][Full Text] [Related]
23. A Review of the Imaging Techniques for Measuring Kidney and Cyst Volume in Establishing Autosomal Dominant Polycystic Kidney Disease Progression.
Magistroni R; Corsi C; Martí T; Torra R
Am J Nephrol; 2018; 48(1):67-78. PubMed ID: 30071518
[TBL] [Abstract][Full Text] [Related]
24. Segmentation of individual renal cysts from MR images in patients with autosomal dominant polycystic kidney disease.
Bae K; Park B; Sun H; Wang J; Tao C; Chapman AB; Torres VE; Grantham JJ; Mrug M; Bennett WM; Flessner MF; Landsittel DP; Bae KT;
Clin J Am Soc Nephrol; 2013 Jul; 8(7):1089-97. PubMed ID: 23520042
[TBL] [Abstract][Full Text] [Related]
25. Plasma metabolites and lipids associate with kidney function and kidney volume in hypertensive ADPKD patients early in the disease course.
Kim K; Trott JF; Gao G; Chapman A; Weiss RH
BMC Nephrol; 2019 Feb; 20(1):66. PubMed ID: 30803434
[TBL] [Abstract][Full Text] [Related]
26. Novel three-dimensional imaging volumetry in autosomal dominant polycystic kidney disease: comparison with 2D volumetry.
Shin D; Lee KB; Hyun YY; Lee YR; Hwang YH; Park HC; Ahn C
Clin Nephrol; 2014 Aug; 82(2):98-106. PubMed ID: 25029513
[TBL] [Abstract][Full Text] [Related]
27. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy.
Alam A; Dahl NK; Lipschutz JH; Rossetti S; Smith P; Sapir D; Weinstein J; McFarlane P; Bichet DG
Am J Kidney Dis; 2015 Oct; 66(4):564-76. PubMed ID: 25960302
[TBL] [Abstract][Full Text] [Related]
28. Geometry-independent assessment of renal volume in polycystic kidney disease from magnetic resonance imaging.
Turco D; Severi S; Mignani R; Magistroni R; Corsi C
Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():3081-4. PubMed ID: 26736943
[TBL] [Abstract][Full Text] [Related]
29. Correlations between renal function and the total kidney volume measured on imaging for autosomal dominant polycystic kidney disease: A systematic review and meta-analysis.
Jo WR; Kim SH; Kim KW; Suh CH; Kim JK; Kim H; Lee JG; Oh WY; Choi SE; Pyo J
Eur J Radiol; 2017 Oct; 95():56-65. PubMed ID: 28987699
[TBL] [Abstract][Full Text] [Related]
30. Volume regression of native polycystic kidneys after renal transplantation.
Jung Y; Irazabal MV; Chebib FT; Harris PC; Dean PG; Prieto M; Cosio FG; El-Zoghby ZM; Torres VE
Nephrol Dial Transplant; 2016 Jan; 31(1):73-9. PubMed ID: 26044834
[TBL] [Abstract][Full Text] [Related]
31. The association of serum angiogenic growth factors with renal structure and function in patients with adult autosomal dominant polycystic kidney disease.
Coban M; Inci A
Int Urol Nephrol; 2018 Jul; 50(7):1293-1300. PubMed ID: 29654395
[TBL] [Abstract][Full Text] [Related]
32. CT of Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: Accuracy, Reproducibility, and Radiation Dose.
Bevilacqua MU; Hague CJ; Romann A; Sheitt H; Vasilescu DM; Yi TW; Levin A
Radiology; 2019 Jun; 291(3):660-667. PubMed ID: 30964424
[TBL] [Abstract][Full Text] [Related]
33. Automatic semantic segmentation of kidney cysts in MR images of patients affected by autosomal-dominant polycystic kidney disease.
Kline TL; Edwards ME; Fetzer J; Gregory AV; Anaam D; Metzger AJ; Erickson BJ
Abdom Radiol (NY); 2021 Mar; 46(3):1053-1061. PubMed ID: 32940759
[TBL] [Abstract][Full Text] [Related]
34. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
35. A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease.
Bhutani H; Smith V; Rahbari-Oskoui F; Mittal A; Grantham JJ; Torres VE; Mrug M; Bae KT; Wu Z; Ge Y; Landslittel D; Gibbs P; O'Neill WC; Chapman AB;
Kidney Int; 2015 Jul; 88(1):146-51. PubMed ID: 25830764
[TBL] [Abstract][Full Text] [Related]
36. Semiautomated Segmentation of Polycystic Kidneys in T2-Weighted MR Images.
Kline TL; Edwards ME; Korfiatis P; Akkus Z; Torres VE; Erickson BJ
AJR Am J Roentgenol; 2016 Sep; 207(3):605-13. PubMed ID: 27341140
[TBL] [Abstract][Full Text] [Related]
37. Hemorrhagic Cysts and Other MR Biomarkers for Predicting Renal Dysfunction Progression in Autosomal Dominant Polycystic Kidney Disease.
Riyahi S; Dev H; Blumenfeld JD; Rennert H; Yin X; Attari H; Barash I; Chicos I; Bobb W; Donahue S; Prince MR
J Magn Reson Imaging; 2021 Feb; 53(2):564-576. PubMed ID: 32969110
[TBL] [Abstract][Full Text] [Related]
38. Clinical and laboratory markers of autosomal dominant polycystic kidney disease (ADPKD) progression: an overview.
Corradi V; Gastaldon F; Virzì GM; Caprara C; Martino F; Ronco C
Minerva Med; 2015 Feb; 106(1):53-64. PubMed ID: 25300895
[TBL] [Abstract][Full Text] [Related]
39. Assessing Risk of Rapid Progression in Autosomal Dominant Polycystic Kidney Disease and Special Considerations for Disease-Modifying Therapy.
Chebib FT; Torres VE
Am J Kidney Dis; 2021 Aug; 78(2):282-292. PubMed ID: 33705818
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.
Torres VE; King BF; Chapman AB; Brummer ME; Bae KT; Glockner JF; Arya K; Risk D; Felmlee JP; Grantham JJ; Guay-Woodford LM; Bennett WM; Klahr S; Meyers CM; Zhang X; Thompson PA; Miller JP;
Clin J Am Soc Nephrol; 2007 Jan; 2(1):112-20. PubMed ID: 17699395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
